Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
www.bitinfocharts.com
bitcoin will run over 8000$ today:)
this company is dead
it's a empty shell
First Berlin Equity Research has published a research update on PAION AG (ISIN: DE000A0B65S3).
Analyst Simon Scholes reiterated his BUY rating and maintained his EUR 4.60 price target.
Abstract: Paion has published comprehensive peer-reviewed results of its phase III trial of remimazolam in procedural sedation of colonoscopy patients in the USA. The results spectacularly confirm the conclusion we drew in June following the headline results - that remimazolam will produce substantial time savings for physicians in comparison with its prospective main competing product, midazolam. While the headline phase III results in combination with the phase IIb results published in 2010 suggested a time saving on a typical 30-60 minute colonoscopy procedure of over six minutes, the comprehensive phase III results show a total combined onset/offset time saving versus midazolam of over 23 minutes! The US colonoscopy market is currently seeing trends towards lower reimbursement per procedure. In this environment, physicians are looking for ways to maintain their income. Remimazolam, which has the advantage over midazolam of shorter onset/offset times and over its other main prospective rival product, propofol, of not requiring an anaesthetist, is a clear potential answer to this problem. In June Paion signed a U.S. licensing deal with Cosmo Pharmaceuticals on the strength of the headline phase III data. We continue to expect late 2017 for filing and late 2018 for approval of remimazolam in the U.S. We maintain our Buy recommendation and price target of EUR4.60.
the end is 0,0001
how many shares are outstandiing now? thx
so
our money is gone
really?today?
no bid
the end
months or years?:)
really?
no bid?
no bid is coming
game over
filing never comes
imo here comes nothing..
yup and no bid
crazy
and 0003:(
imo
this stock is dead
yup very hot...lol
0001 is coming...
no sales
nothing
the end us 0001 with no bid
imo here comes nothing
yes but the 72 mill are sells
one buyer one seller
all sells...
new year new game
right:)
yup
who or what is buying all this shares?
which year?
its going to 0001
sell off
christmas @0001
holding 7,25 mill. shared since 2005
and ? bad like the others
It works on windowsphone? Thx
How you get your information?thx
Yes right